GEN Exclusives

More »

GEN News Highlights

Back to Item »

Spirogen Receives About $24M for Clinical-Stage Anticancer Drug and Reacquires Development Rights

Celtic Therapeutics invests in continued development of SG2000, while Ipsen passes rights back to Spirogen.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?